Who owns VIRIOS THERAPEUTICS ORD?

Tip: Access positions for across all investors

Analyze quarterly positions in Virios Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Virios Therapeutics Ord stock

Who bought or sold VIRIOS THERAPEUTICS ORD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 209k $100k 0% Mar 2024
 View chart
Geode Capital Management 175k $84k 0% Mar 2024
 View chart
McCollum Christoferson Group 42k $20k 14% Mar 2024
 View chart
Raymond James & Associates 30k $14k 0% Mar 2024
 View chart
Northern Trust 24k $12k 0% Mar 2024
 View chart
Susquehanna International 23k $11k -80% Mar 2024
 View chart
Regions Bank 20k $9.6k 0% Mar 2024
 View chart
Northwestern Mutual Wealth Management Company 19k $9.1k 100% Mar 2024
 View chart
Jane Street 17k $8.1k 100% Mar 2024
 View chart
Morgan Stanley 15k $7.2k 0% Mar 2024
 View chart
Wiley Bros.-aintree Capital 11k $5.3k 0% Mar 2024
 View chart
William Howard & Co Financial Advisors 10k $5.0k 100% Mar 2024
 View chart
Group One Trading 8.1k $3.9k -29% Mar 2024
 View chart
Tower Research Capital 6.8k $3.3k -22% Mar 2024
 View chart
Cutler 2.3k $1.0k 0% Mar 2024
 View chart
BlackRock 755.00 $362.022500 0% Mar 2024
 View chart
Wells Fargo & Company 133.00 $63.999600 2% Mar 2024
 View chart
Royal Bank of Canada 56.00 $0 0% Mar 2024
 View chart

Who sold out of Virios Therapeutics Ord?

Fund or Company Name Date Sold Shares Held Valued At
Virtu Financial Sep 2023 27k $25k
Simplex Trading Dec 2023 17k $9.0k
XTX Topco Sep 2023 14k $13k
UBS Group Dec 2023 2.6k $1.5k